Phenotypic screening using iPSC-based human disease biology
18 February 2019 | By Tecan and Ncardia
Ncardia, will discuss the application of human iPSC-derived cell-based assays and high throughput screening for drug discovery and development.
List view / Grid view
Translational Science
Intellicyt® T Cell Activation Cell and Cytokine Profiling Kit
17 January 2019 | By IntelliCyt, a Sartorius Company
Multiplexed approach to measure T-cell activation, proliferation and quantify cytokine release in a single well
Whitepaper: The most important mouse in the world: the utility and applications of C57BL/6 models
10 January 2019 | By Taconic Biosciences
Learn everything you need to know about the most widely-used mouse in biomedical research with this free whitepaper.
Whitepaper: Application of CRISPR/Cas to the generation of genetically engineered mice
7 January 2019 | By Taconic Biosciences
Learn how the continued development of CRISPR gene editing technologies opens fresh possibilities for in vivo model design.
slincR gene could shed light on chemical exposure effects in humans
26 November 2018 | By Drug Target Review
The discovery of a new gene in zebrafish could lead to a better understanding of how exposure to chemicals leads to disease in humans...
High throughput screening for deep mining of antibody repertoires, Dr. Stefan Moese, Novartis, Switzerland
9 November 2018 | By Beckman Coulter
In this webinar you learn about a high throughput screening approach for mining of antibody repertoires in the context of biologics drug discovery.
Harmonising drug-target binding data analytics on a single platform
6 November 2018 | By PerkinElmer
This webinar outlined the fundamentals of a design process where an experimental analytics data workflow is being integrated into a more seamlessly interactive platform...
NIH to build cell atlas of the human body
28 September 2018 | By Iqra Farooq (Drug Target Review)
The NIH's Common Fund programme looks towards building a cell map of all individual cells in the human body to aid the detection of disease...
Blocking RNA-silencing protein Ago2 shows promise for obesity prevention
12 September 2018 | By Drug Target Review
Researchers are hopeful of finding a means to inhibit obesity and its associated health problems after a study in which they blocked an RNA-silencing protein in the livers of mice, preventing obesity and diabetic conditions.
Recent advances in diagnostics and treatments – from small molecules to cellular therapies
10 September 2018 | By Sheraz Gul
This webinar, supported by Bio-Techne, will trace the journey of medical treatments from small molecule to cellular therapies. It will take place on 16 October 2018 at 3.00pm (BST).
Using bioactivity profiling to support the progression of phenotypic hits
7 September 2018 | By DiscoverX Corporation, Eurofins Pharma Discovery Services
This webinar, held on 28 June 2018, illustrated the optimisation of hits derived from a target-agnostic phenotypic screen, using a strategy based on combining bioactivity profiling and reference compound characterisation. Keynote speaker Arsenio Nueda, Head of Molecular Biology at Almirall, responded as follows to questions posed during the webinar.
Computational analysis identifies a new clinical phenotype of severe malaria
4 September 2018 | By Drug Target Review
Researchers have applied a computational analysis based on networks in order to identify biologically relevant phenotypes apart from those currently defined by the WHO...
Recent advances in diagnostics and treatments – from small molecules to cellular therapies
14 August 2018 | By Bio-Techne
With recent advances in medicine, cellular therapies are one step closer to becoming a reality where re-programmed cells, tissues and organs can be used as therapeutic agents. This webinar discussed the journey of medical treatments from small molecule to cellular therapies...
Follow: